SCHEMBL22717633

SCHEMBL22717633

CC(Oc1nnc(N)s1)c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.47
BRD4 O60885 1/20 0.47
KDM4E B2RXH2 3/20 0.44
RAB9A P51151 2/20 0.44
HPGD P15428 2/20 0.44
NPC1 O15118 1/20 0.44
MGAM O43451 2/20 0.44
GAA P10253 2/20 0.44
SI P14410 2/20 0.44
MGAM2 Q2M2H8 2/20 0.44
NOTUM Q6P988 1/20 0.44
ALDH1A1 P00352 4/20 0.41
LMNA P02545 2/20 0.41
FBP1 P09467 1/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
ADRB2 P07550 1/20 0.39
SCN9A Q15858 1/20 0.38
POLB P06746 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24500312 0.80 SMN1; SMN2 (0.43) SMN1; SMN2BRD4KDM4ERAB9AHPGD
SCHEMBL22717904 0.79 ALDH1A1 (0.36) SMN1; SMN2KDM4ERAB9AHPGDNPC1
SCHEMBL26599180 0.72 KMT2A (0.70) SMN1; SMN2BRD4KDM4ERAB9AHPGD
SCHEMBL11385461 0.72 ALDH1A1 (0.77) SMN1; SMN2BRD4KDM4EHPGDMGAM
SCHEMBL24769981 0.72 GAA (0.42) SMN1; SMN2BRD4KDM4ERAB9AHPGD
SCHEMBL22717882 0.68 ALDH1A1 (0.54) SMN1; SMN2KDM4EMGAMGAASI
SCHEMBL22717405 0.68 ALDH1A1 (0.54) SMN1; SMN2KDM4EMGAMGAASI
SCHEMBL31083418 0.67 MEN1 (0.66) SMN1; SMN2KDM4ERAB9AHPGDNPC1
SCHEMBL29151288 0.66 KDM4E (0.43) KDM4ERAB9AALDH1A1KMT2AMEN1
SCHEMBL8614780 0.66 IDO1 (0.58) BRD4HPGDLMNAADRB2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260049074-A1 THIADIAZOLYL DERIVATIVES IDEAYA BIOSCIENCES, INC. (US) 2026-02-19 US disclosed
US-12509454-B2 Thiadiazolyl derivatives IDEAYA BIOSCIENCES, INC. (US) 2025-12-30 US disclosed
EP-3976608-B1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES INC (US) 2023-11-08 EP disclosed
EP-3976608-B1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES INC (US) 2023-11-08 EP disclosed
US-20230078112-A1 THIADIAZOLYL DERIVATIVES IDEAYA BIOSCIENCES, INC. 2023-03-16 US disclosed
EP-3976608-A1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS Ideaya Biosciences, Inc. (US) 2022-04-06 EP disclosed
WO-2020243459-A1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2020-12-03 WO disclosed
WO-2020243459-A1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2020-12-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260049074-A1 THIADIAZOLYL DERIVATIVES POLH, POLM, POLD1 SMN1; SMN2 4185/4885BRD4 1653/4885KDM4E 3719/4885
US-20230078112-A1 THIADIAZOLYL DERIVATIVES POLQ, POLK, POLA1 SMN1; SMN2 3104/4885BRD4 1884/4885KDM4E 3851/4885
US-12509454-B2 Thiadiazolyl derivatives POLD1, POLQ, DNA2 SMN1; SMN2 1964/4885BRD4 2820/4885KDM4E 3903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.